Accuray (ARAY) Asset Writedowns and Impairment (2010 - 2026)
Accuray's (ARAY) quarterly Asset Writedowns and Impairment came in at $1.2 million in Q1 2026, down 50.36% year-on-year from $2.3 million in Q1 2025, and down 4.04% quarter-over-quarter from $1.2 million in Q4 2025.
Accuray (ARAY) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Accuray's Asset Writedowns and Impairment history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 50.36% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 84.44% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, down 63.2% from the prior year.
- Asset Writedowns and Impairment eased to $1.2 million in Q1 2026 per ARAY's latest filing, from $1.2 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $2.6 million in Q1 2023 and bottomed at -$145000.0 in Q1 2024.
- The 5-year median for Asset Writedowns and Impairment is $577000.0 (2022), against an average of $763500.0.
- Across the five-year window, Asset Writedowns and Impairment sank 334.78% in 2023 and jumped 1715.86% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $91000.0 in 2022, then plunged by 229.67% to -$118000.0 in 2023, then soared by 873.73% to $913000.0 in 2024, then soared by 32.75% to $1.2 million in 2025, then slipped by 4.04% to $1.2 million in 2026.
- Per Business Quant, the three latest ARAY Asset Writedowns and Impairment figures stand at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Accuray | 27,968.40 | -38.51 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Mar 31, 2025 | 2.34 Mn |
| Sep 30, 2024 | 913,000.00 |
| Sep 30, 2024 | 913,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | -118,000.00 |
| Dec 31, 2023 | -118,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Mar 31, 2023 | 2.57 Mn |
| Mar 31, 2023 | 2.57 Mn |
| Dec 31, 2022 | 91,000.00 |
| Dec 31, 2022 | 91,000.00 |